BR112022017316A2 - Vacina para proteção contra streptococcus suis de sorotipo 9, sequência tipo 16 - Google Patents

Vacina para proteção contra streptococcus suis de sorotipo 9, sequência tipo 16

Info

Publication number
BR112022017316A2
BR112022017316A2 BR112022017316A BR112022017316A BR112022017316A2 BR 112022017316 A2 BR112022017316 A2 BR 112022017316A2 BR 112022017316 A BR112022017316 A BR 112022017316A BR 112022017316 A BR112022017316 A BR 112022017316A BR 112022017316 A2 BR112022017316 A2 BR 112022017316A2
Authority
BR
Brazil
Prior art keywords
sequence
type
streptococcus suis
vaccine
protection against
Prior art date
Application number
BR112022017316A
Other languages
English (en)
Portuguese (pt)
Inventor
Arnoldus Christiaan Jacobs Antonius
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of BR112022017316A2 publication Critical patent/BR112022017316A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BR112022017316A 2020-03-14 2021-03-12 Vacina para proteção contra streptococcus suis de sorotipo 9, sequência tipo 16 BR112022017316A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20163206 2020-03-14
PCT/EP2021/056285 WO2021185680A1 (en) 2020-03-14 2021-03-12 A vaccine for protection against streptococcus suis serotype 9, sequence type 16

Publications (1)

Publication Number Publication Date
BR112022017316A2 true BR112022017316A2 (pt) 2022-10-11

Family

ID=69844613

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022017316A BR112022017316A2 (pt) 2020-03-14 2021-03-12 Vacina para proteção contra streptococcus suis de sorotipo 9, sequência tipo 16

Country Status (6)

Country Link
US (1) US12383610B2 (cg-RX-API-DMAC7.html)
EP (1) EP4117721A1 (cg-RX-API-DMAC7.html)
JP (1) JP7728784B2 (cg-RX-API-DMAC7.html)
CN (1) CN115243715B (cg-RX-API-DMAC7.html)
BR (1) BR112022017316A2 (cg-RX-API-DMAC7.html)
WO (1) WO2021185680A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4380610A1 (en) * 2021-08-03 2024-06-12 Intervet International B.V. A vaccine for protection against streptococcus suis of various serotypes
JP2024528172A (ja) * 2021-08-03 2024-07-26 インターベット インターナショナル ベー. フェー. 様々な血清型のストレプトコッカス・スイスに対する防御のためのワクチン
US20240325514A1 (en) * 2021-08-03 2024-10-03 Intervet Inc. A vaccine for protection against streptococcus suis of various serotypes
CN113832068B (zh) * 2021-10-14 2023-07-25 河南兴华生物技术有限公司 链球菌菌株及防治猪链球菌病的疫苗

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201402264D0 (en) 2014-02-10 2014-03-26 Wellstream Int Ltd Composite
EP2949340A1 (en) 2014-05-30 2015-12-02 IDT Biologika GmbH Vaccine composition against Streptococcus suis infection
US11155585B2 (en) 2015-07-09 2021-10-26 Intervacc Ab Vaccine against S. suis infection
CN111447946A (zh) * 2017-12-15 2020-07-24 英特维特国际股份有限公司 用于针对猪链球菌进行保护的疫苗
CN111447945A (zh) * 2017-12-15 2020-07-24 英特维特国际股份有限公司 用于保护以抗猪链球菌的疫苗
WO2020094762A1 (en) 2018-11-08 2020-05-14 Intervet International B.V. A vaccine for protection against streptococcus suis

Also Published As

Publication number Publication date
CN115243715B (zh) 2025-12-16
WO2021185680A1 (en) 2021-09-23
CN115243715A (zh) 2022-10-25
US12383610B2 (en) 2025-08-12
JP2023517684A (ja) 2023-04-26
EP4117721A1 (en) 2023-01-18
JP7728784B2 (ja) 2025-08-25
US20240197851A1 (en) 2024-06-20

Similar Documents

Publication Publication Date Title
MX2010005014A (es) Vacuna viva avirulenta de mycoplasma hyopneumoniae con adyuvante.
MX395525B (es) Composiciones inmunogenicas para usar en vacunas neumococicas.
CO6180452A2 (es) Reduccion de nfecciones concomitantes en cerdos mediante el uso de antigeno pcv2
BR112012023046A2 (pt) vacinas de vírus de febre aftosa recombinantes e seus respectivos usos
BR112021019028A2 (pt) Uma vacina para proteção contra streptococcus suis
RU2020119271A (ru) Вакцина для защиты от streptococcus suis
CO6361948A2 (es) Uso de antigeno de mycoplasma bovis
CL2016002402A1 (es) Composiciones inmunológicas que contiene histophilus somni atenuado
MX2021014948A (es) Metodos de tratamiento de pacientes con una composicion inmunogenica que protege contra el seroripo 29 de s. pneumoniae.
MX2019005499A (es) Atenuacion de virulencia bacteriana mediante atenuacion de transporte de folato bacteriano.
BR112018069100A2 (pt) uma vacina combinada contra a infecção por vírus pcv2 e mycoplasma hyopneumoniae
MX373395B (es) Vacuna de haemophilus parasuis para serovar tipo cuatro.
BR112022005345A2 (pt) Composições imunogênicas
RU2020109137A (ru) Вакцина для защиты от streptococcus suis
BR112019004303A2 (pt) composição de conjugados multivalentes de polissacarídeo capsular pneumocócico-proteína portadora e uso da mesma
MY191905A (en) M hyo multivalent vaccine and uses thereof
BR112016012393A8 (pt) vacina, e, uso de uma combinação de um vírus prrs atenuado vivo e um antígeno de lawsonia intracellularis inativado
CL2023002187A1 (es) Virus para vacuna contra el síndrome respiratorio y reproductivo porcino
MX2018012270A (es) Novedosas formulaciones de vacuna neumococica.
PL404247A1 (pl) Koniugat oligocukru LOS Bordetella pertussis i toksyny krztuśca i jego zastosowanie w profilaktyce i leczeniu zakażeń wywoływanych przez Bordetella pertussis
CU24709B1 (es) Ácido nucleico que codifica la proteína de superficie neumocócica a1 (pspa1) truncada, constructo de expresión para la expresión de alto nivel de la misma y vacuna conjugada neumocócica
MX2019012220A (es) Vacunas que contienen patogenos de cerdo para uso no mixto asociado.
EP4635510A3 (en) Combination vaccine
MX2020006061A (es) Una vacuna para proteccion contra streptococcus suis.
WO2019157188A3 (en) Compositions and methods for cross-protection against pneumococcal disease